Hybrid Inhibitors

Controlling the spread of the highly contagious disease and protecting human health requires developing new medications that stay effective against growing COVID-19 variations. After spending more than two years studying SARS-CoV-2, the virus that causes COVID-19, the researchers at the Department of Energy’s (DOE) Oak Ridge National Laboratory (ORNL) are designing and testing small-molecule antivirals…